POSACONAZOLE
NDC 70748-258, POSACONAZOLE, tablet, delayed release, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-258
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213454
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-258 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POSACONAZOLE100 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-258-07 | 70748025807 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (70748-258-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/548124ce-8050-46a9-967b-ff23dfb18633NADAC price for package 70748025807
GET /v1/drugs/nadac/70748025807
Use it
Look up 70748-258 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-258 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-258. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.